报价延迟最少15分钟:2026/06/05 21:16 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.01 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.12/--
|
|
企业价值
222.76M
|
| 资产负债 |
|
每股账面净值
-0.04
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
596.82K
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue. |
